Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, 18F-FMISO PET, and 18F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma

被引:15
作者
Collet, Solene [1 ,2 ]
Guillamo, Jean-Sebastien [1 ,3 ,4 ]
Berro, David Hassanein [1 ,5 ]
Chakhoyan, Ararat [1 ]
Constans, Jean-Marc [1 ,6 ]
Lechapt-Zalcman, Emmanuele [1 ,7 ,8 ]
Derlon, Jean-Michel [1 ]
Hatt, Mathieu [9 ]
Visvikis, Dimitris [9 ]
Guillouet, Stephane [10 ]
Perrio, Cecile [10 ]
Bernaudin, Myriam [1 ]
Valable, Samuel [1 ]
机构
[1] Normandie Univ, GIP Cyceron, ISTCT CERVOxy Grp, CNRS,UNICAEN,CEA, Caen, France
[2] Ctr Francois Baclesse, Radiophys Dept, Caen, France
[3] CHU Caen, Dept Neurol, Caen, France
[4] CHU Nimes, Dept Neurol, Nimes, France
[5] CHU Caen, Dept Neurosurg, Caen, France
[6] CHU Caen, Dept Neuroradiol, Caen, France
[7] CHU Caen, Dept Pathol, Caen, France
[8] GHU Paris Psychiat & Neurosci, Dept Neuropathol, Paris, France
[9] Univ Brest, INSERM, LaTIM, UMR 1101, Brest, France
[10] Normandie Univ, UNICAEN, CEA, CNRS,ISTCT LDM TEP Grp,GIP Cyceron, Caen, France
关键词
proliferation; vasculature; hypoxia; MRI; PET; glioblastoma; POSITRON-EMISSION-TOMOGRAPHY; TUMOR HYPOXIA; RADIOTHERAPY; GLIOMA; ANGIOGENESIS; TEMOZOLOMIDE; CLASSIFICATION; SEGMENTATION; PROGRESSION; SURVIVAL;
D O I
10.2967/jnumed.120.249524
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Conventional MRI plays a key role in the management of patients with high-grade glioma, but multiparametric MRI and PET tracers could pro-vide further information to better characterize tumor metabolism and heterogeneity by identifying regions having a high risk of recurrence. In this study, we focused on proliferation, hypervascularization, and hypoxia, all factors considered indicative of poor prognosis. They were assessed by measuring uptake of F-18-3'-deoxy-3'-F-18-fluorothy-midine (F-18-FLT), relative cerebral blood volume (rCBV) maps, and uptake of F-18-fluoromisonidazole (F-18-FMISO), respectively. For each modality, the volumes and high-uptake subvolumes (hot spots) were semiautomatically segmented and compared with the contrast enhancement (CE) volume on T1-weighted gadolinium-enhanced (T1w-Gd) images, commonly used in the management of patients with glioblastoma. Methods: Dynamic susceptibility contrast-enhanced MRI (31 patients), F-18-FLT PET (20 patients), or F-18-FMISO PET (20 patients), for a total of 31 patients, was performed on preoper-ative glioblastoma patients. Volumes and hot spots were segmented on SUV maps for F-18-FLT PET (using the fuzzy locally adaptive bayesian algorithm) and F-18-FMISO PET (using a mean contralateral image + 3.3 SDs) and on rCBV maps (using a mean contralateral image + 1.96 SDs) for dynamic susceptibility contrast-enhanced MRI and overlaid on T1w-Gd images. For each modality, the percentages of the periph-eral volumes and the peripheral hot spots outside the CE volume were calculated. Results: All tumors showed highly proliferated, hypervascu-larized, and hypoxic regions. The images also showed pronounced het-erogeneity of both tracers regarding their uptake and rCBV maps, within each individual patient. Overlaid volumes on T1w-Gd images showed that some proliferative, hypervascularized, and hypoxic regions extended beyond the CE volume but with marked differences between patients. The ranges of peripheral volume outside the CE volume were 1.6%-155.5%, 1.5%-89.5%, and 3.1%-78.0% for F-18-FLT, rCBV, and F-18-FMISO, respectively. All patients had hyperproliferative hot spots outside the CE volume, whereas hypervascularized and hypoxic hot spots were detected mainly within the enhancing region. Conclu-sion: Spatial analysis of multiparametric maps with segmented volumes and hot spots provides valuable information to optimize the manage-ment and treatment of patients with glioblastoma.
引用
收藏
页码:1349 / 1356
页数:8
相关论文
共 50 条
  • [1] Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome
    Arens, Anne I. J.
    Troost, Esther G. C.
    Hoeben, Bianca A. W.
    Grootjans, Willem
    Lee, John A.
    Gregoire, Vincent
    Hatt, Mathieu
    Visvikis, Dimitris
    Bussink, Johan
    Oyen, Wim J. G.
    Kaanders, Johannes H. A. M.
    Visser, Eric P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 915 - 924
  • [2] [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis
    Bekaert, Lien
    Valable, Samuel
    Lechapt-Zalcman, Emmanuele
    Ponte, Keven
    Collet, Solene
    Constans, Jean-Marc
    Levallet, Guenaelle
    Bordji, Karim
    Petit, Edwige
    Branger, Pierre
    Emery, Evelyne
    Manrique, Alain
    Barre, Louisa
    Bernaudin, Myriam
    Guillamo, Jean-Sebastien
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) : 1383 - 1392
  • [3] The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
    Bergmann, Natalie
    Delbridge, Claire
    Gempt, Jens
    Feuchtinger, Annette
    Walch, Axel
    Schirmer, Lucas
    Bunk, Wolfram
    Aschenbrenner, Thomas
    Liesche-Starnecker, Friederike
    Schlegel, Juergen
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Comparison between MRI-derived ADC maps and 18FLT-PET in pre-operative glioblastoma
    Berro, David Hassanein
    Collet, Solene
    Constans, Jean-Marc
    Barre, Louisa
    Derlon, Jean-Michel
    Emery, Evelyne
    Guillamo, Jean-Sebastien
    Valable, Samuel
    [J]. JOURNAL OF NEURORADIOLOGY, 2019, 46 (06) : 359 - 366
  • [5] Boxerman JL, 2006, AM J NEURORADIOL, V27, P859
  • [6] Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study
    Brahm, Cyrillo G.
    den Hollander, Martha W.
    Enting, Roelien H.
    de Groot, Jan Cees
    Solouki, A. Millad
    den Dunnen, Wilfred F. A.
    Heesters, Mart A. A. M.
    Wagemakers, Michiel
    Verheul, Henk M. W.
    de Vries, Elisabeth G. E.
    Pruim, Jan
    Walenkamp, Annemiek M. E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (13) : 2404 - 2412
  • [7] FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas
    Chakhoyan, Ararat
    Guillamo, Jean-Sebastien
    Collet, SolSne
    Kauffmann, Francois
    Delcroix, Nicolas
    Lechapt-Zalcman, Emmanuele
    Constans, Jean-Marc
    Petit, Edwige
    MacKenzie, Eric T.
    Barre, Louisa
    Bernaudin, Myriam
    Touzani, Omar
    Valable, Samuel
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [8] Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345
  • [9] [18F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas
    Collet, S.
    Valable, S.
    Constans, J. M.
    Lechapt-Zalcman, E.
    Roussel, S.
    Delcroix, N.
    Abbas, A.
    Ibazizene, M.
    Bernaudin, M.
    Barre, L.
    Derlon, J. M.
    Guillamo, J. S.
    [J]. NEUROIMAGE-CLINICAL, 2015, 8 : 448 - 454
  • [10] Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy
    Corroyer-Dulmont, Aurelien
    Peres, Elodie A.
    Petit, Edwige
    Guillamo, Jean-Sebastien
    Varoqueaux, Nathalie
    Roussel, Simon
    Toutain, Jerome
    Divoux, Didier
    MacKenzie, Eric T.
    Delamare, Jerome
    Ibazizene, Meziane
    Lecocq, Myriam
    Jacobs, Andreas H.
    Barre, Louisa
    Bernaudin, Myriam
    Valable, Samuel
    [J]. NEURO-ONCOLOGY, 2013, 15 (01) : 41 - 56